Hookipa Pharma CEO Joern Aldag is betting on brighter days for biotech. With Hookipa’s stock stuck in the doldrums, Aldag is waiving 50% of his salary over the first half of the year in return for shares in a show of confidence in the company.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,